Astrazeneca (NYSE:AZN) Shares Gap Up - Here's What Happened

NodeGuardian · 2026-03-29T09:16:07+00:00

AstraZeneca shares rose 3.6% pre-market, opening at $190.88. Analysts maintain a "Moderate Buy" rating with a price target of $95.75. The company announced a dividend yield of 156.0% and a market cap of $294.5 billion.

NodeGuardian

2026-03-29 09:16:07

Abstract generation in progress

AstraZeneca (NYSE:AZN) shares gapped up pre-market, opening at $190.88 and trading around $190.35, up about 3.6%. The company has received largely positive analyst sentiment, with a “Moderate Buy” consensus rating and a consensus price target of $95.75, backed by recent reiterations from firms like Morgan Stanley and Barclays. AstraZeneca also disclosed a dividend of $1.595, reflecting a 156.0% yield, and reported strong company metrics including a market cap of $294.5 billion.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes